Study guide
14.2 Home Nutrition Support (HNS) & Care Transitions
Certified Nutrition Support Clinician CNSC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Nutrition Screening, Dietary Evaluation & Energy Requirements
1.1 Nutrition Screening & Validated Risk Tools 1.2 Dietary History & Nutrient Intake Assessment 1.3 Energy Expenditure Estimation & Indirect Calorimetry
2 Chapter 2: Macronutrients, Micronutrients & Fluid Management
2.1 Protein Requirements & Nitrogen Balance 2.2 Fluid Requirements & Electrolyte Homeostasis 2.3 Essential Vitamins & Trace Elements
3 Chapter 3: Anthropometrics, Physical Exam & Malnutrition Consensus
3.1 Anthropometric Assessment & Body Composition 3.2 Nutrition-Focused Physical Examination (NFPE) 3.3 AND/ASPEN & GLIM Malnutrition Criteria
4 Chapter 4: Pediatric & Specialized Nutrition Assessment
4.1 Pediatric & Neonatal Nutrition Assessment 4.2 Biochemical Assessment, Visceral Proteins & Inflammation
5 Chapter 5: Enteral Nutrition Access & Tube Management
5.1 Enteral Access Modalities & Route Selection 5.2 Tube Placement Verification & Stoma Site Care
6 Chapter 6: Enteral Formulation, Regimen Design & Administration
6.1 Enteral Formula Classification & Selection 6.2 Enteral Delivery Methods & Infusion Schedules 6.3 Enteral Fluid Management & Free Water Requirements
7 Chapter 7: Enteral Complications & Medication Administration
7.1 Enteral Gastrointestinal Complications 7.2 Enteral Metabolic, Mechanical & Pulmonary Complications 7.3 Drug-Nutrient Interactions & Enteral Medication Delivery
8 Chapter 8: Parenteral Nutrition Indications, Access & Formulation Design
8.1 Parenteral Nutrition Indications & Venous Access Routes 8.2 Peripheral Parenteral Nutrition (PPN) Parameters 8.3 Central PN Macronutrient Formulation
9 Chapter 9: Parenteral Additives, Compounding & Physical Stability
9.1 Parenteral Electrolytes, Trace Elements & Vitamins 9.2 Calcium-Phosphate Solubility & Precipitation Risks 9.3 Physical Stability, Total Nutrient Admixtures & Filtration
10 Chapter 10: Parenteral Complications, CLABSI & Organ Toxicities
10.1 Central Line-Associated Bloodstream Infections & Mechanical Risks 10.2 Refeeding Syndrome Pathophysiology & Prevention 10.3 Parenteral Nutrition-Associated Liver Disease & Metabolic Bone Disease
11 Chapter 11: Critical Care, Obesity & Pulmonary Nutrition Support
11.1 Critical Illness, Sepsis & Trauma Nutrition 11.2 Nutrition Support in Obesity & Hypocaloric Feeding 11.3 Pulmonary Failure & Mechanical Ventilation 11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment
12 Chapter 12: Organ Failure: Renal, Hepatic & Gastrointestinal Support
12.1 Acute Kidney Injury & Renal Replacement Therapy 12.2 Cirrhosis, Hepatic Encephalopathy & Acute Pancreatitis 12.3 Short Bowel Syndrome & Intestinal Failure
13 Chapter 13: Oncology, Surgical Care & Intestinal Failure
13.1 Oncology Nutrition & Cancer Cachexia 13.2 Perioperative Nutrition & Enhanced Recovery After Surgery (ERAS) 13.3 Enterocutaneous Fistulas & Severe Malabsorption
14 Chapter 14: Process Management, Compounding Safety & Home Nutrition Support
14.1 PN Order Verification, Compounding Safety & USP Standards 14.2 Home Nutrition Support (HNS) & Care Transitions 14.3 Nutrition Support Policies, Product Shortages & Patient Education
15 Chapter 15: Professional Practice, Ethics & Interdisciplinary Care
15.1 Ethical Principles & Withholding/Withdrawing Artificial Nutrition 15.2 The Interdisciplinary Nutrition Support Team 15.3 Quality Improvement, Malnutrition Documentation & Clinical Standards 15.4 Critical Appraisal of Nutrition Research & Evidence
14.2 Home Nutrition Support (HNS) & Care Transitions
Key Takeaways Explain This Topic AI
Candidates for Home Nutrition Support must be medically stable with established fluid and electrolyte homeostasis, anticipated to require specialized nutrition for > 30 days > 30\text{ days} > 30 days , and possess capable cognitive/physical abilities or a committed caregiver alongside a safe home environment.
Cyclic PN can improve daytime mobility and create a daily infusion-free period, but cycle duration, glucose monitoring, and any ramp-up or taper are individualized rather than universally fixed.
A start or stop taper may be appropriate for patients at risk of glucose instability, especially infants, children, or adults with prior symptoms; follow the prescribed protocol and monitor rather than treating a one-hour taper as mandatory for every adult.
Comprehensive patient and caregiver education covers aseptic central line care using the SASH flushing protocol, weekly chlorhexidine dressing changes, portable ambulatory pump troubleshooting, and immediate recognition of early catheter-related bloodstream infection signs.
Medicare EN/PN coverage is governed through current DME MAC local coverage policy. “Permanent” means the treating practitioner expects the impairment to be of long and indefinite duration; current policy does not impose a universal 90-day minimum.
Last updated: October 2026
14.2 Home Nutrition Support (HNS) & Care Transitions
Clinical Core: Safe home enteral nutrition (HEN) and home parenteral nutrition (HPN) depend on much more than writing a discharge formula. The team must verify the ongoing indication, metabolic and hemodynamic stability, vascular or enteral access, patient or caregiver competency, a safe home environment, coverage and supply continuity, and a named clinician who will review laboratory results and adjust therapy.
Candidate and Environment Assessment
A candidate should have a continuing need that cannot be met safely by ordinary oral intake, a regimen that can be delivered in the home, and clinical stability sufficient for outpatient management. Before discharge, confirm that acute electrolyte and glucose problems are controlled, the access device functions, and the patient is tolerating a reproducible regimen.
The patient or caregiver must demonstrate—not merely verbalize—hand hygiene, aseptic or clean technique appropriate to the therapy, pump setup, medication separation, flushing, storage, troubleshooting, and emergency response. Evaluate vision, dexterity, cognition, language, health literacy, refrigeration, clean water, electricity, telephone access, transportation, and the availability of backup supplies. Arrange interpreter and accessible-format support when needed.
Transition Checklist
Domain Required handoff elements
Indication and goals Diagnosis, route, measurable short- and long-term goals, expected duration, criteria to modify or stop
Prescription Product, volume, dose, infusion schedule, water, electrolytes, additives, filter and tubing requirements
Access Device type and tip or stoma status, dressing and connector plan, flushing and declogging instructions
Monitoring Laboratory tests, weights, intake/output, glucose plan, frequency, responsible reviewer, action thresholds
Safety Fever and sepsis response, occlusion, breakage, dislodgement, pump failure, hypoglycemia, dehydration, emergency contacts
Logistics Home infusion or DME supplier, delivery dates, backup pump or gravity plan, insurance authorization, follow-up appointment
Use closed-loop communication: the receiving clinician, home infusion pharmacy, nursing agency, patient, and caregiver should receive the same final prescription. Medication reconciliation must identify drugs that cannot be crushed, drugs that interact with formula, and drugs added to or administered separately from PN.
Cycling Parenteral Nutrition
Cyclic PN delivers the daily prescription over fewer than 24 hours, often overnight, to permit mobility and an infusion-free period. It may be useful for long-term home therapy, but it is not mandatory for every patient. Cycle length is individualized to age, dextrose load, glucose tolerance, fluid tolerance, liver disease, lifestyle, and pump capability.
Some patients require gradual compression over several days. A ramp-up or ramp-down may be used when a patient has prior glucose instability, is very young, receives a high glucose infusion rate, or has symptoms when an infusion starts or stops. It is inaccurate to prescribe a universal one-hour taper as essential for every stable adult. Follow the home-infusion protocol, check glucose when clinically indicated, and teach treatment of symptomatic hypoglycemia. If PN is interrupted unexpectedly, the response depends on symptoms, glucose concentration, insulin exposure, and the expected duration of interruption.
Patient and Caregiver Education
Use demonstration and teach-back for every high-risk skill. Education should cover:
Hand hygiene and a clean work surface.
Product inspection for leaks, particles, precipitate, separation, damage, or an incorrect label.
Refrigerated storage when required and removal from refrigeration according to supplier instructions.
Pump programming, tubing and filter setup, connection, disconnection, flushing, and disposal.
Catheter or tube site assessment and dressing or stoma care.
Recognition of fever, chills, dyspnea, edema, dehydration, tube dislodgement, leakage, occlusion, or pump failure.
Which number to call during business hours and after hours, and which findings require emergency services.
Competency is documented when the learner independently performs the full sequence and explains the emergency plan. Provide plain-language, language-concordant written instructions that exactly match the equipment and product supplied at home.
Monitoring After Discharge
Early follow-up is more frequent while the regimen and fluid/electrolyte balance stabilize. Monitor weight trend, hydration, intake and output when relevant, access-device condition, actual delivered volume, gastrointestinal tolerance, functional status, and progress toward goals. Laboratory selection and frequency are individualized; commonly reviewed measures include electrolytes, glucose, renal function, magnesium, phosphorus, liver tests, triglycerides for PN, blood count, and selected micronutrients during long-term therapy.
Every result needs an owner and an action threshold. A laboratory order without a designated reviewer is an unsafe transition. Reassess whether the original route and dose remain necessary as oral or enteral tolerance improves.
Current Medicare Coverage Framework
The former national coverage determination for enteral and parenteral nutritional therapy, NCD 180.2, was retired effective April 10, 2023 . Coverage is now operationalized through the applicable Durable Medical Equipment Medicare Administrative Contractor local coverage determination and policy article, including LCD L38953 and Article A58836 where applicable. Clinicians must check the current policy for the beneficiary’s jurisdiction rather than citing the retired NCD as active.
Under current policy, the treating practitioner must document why the impairment prevents food from reaching or being absorbed from the small bowel and why enteral nutrition has been considered, ruled out, failed, or would exacerbate the gastrointestinal dysfunction when PN is requested. The record must support the prescribed nutrients, route, frequency, duration, and medical necessity.
The prosthetic-device benefit uses “permanent” to mean that the treating practitioner expects the impairment to be of long and indefinite duration . Current policy does not define permanence as a universal minimum of 90 days. Coverage decisions are documentation- and policy-specific; a clinician should never promise payment based only on diagnosis or an invented duration threshold.